Abstract: The method for on-board electrical power distribution according to the invention includes the producing a protected segregation interface (4A) between the primary distribution (2A) and the secondary distribution network for electrical power of the cabin system (30), referred to as the cabin network, so as to comply with the quality parameters for the primary distribution (2A); controlling the extraction of electrical power from the primary distribution (2A) by a cabin management system (G1, G2) depending on the availability of electrical power on this primary distribution (2A); converting and distributing this available electrical power in the cabin network (30) according to a suitable configuration of the loads (51, 52, 53) of this cabin network (30) and defined according to an electrical configuration of type, single/three-phase AC and DC, as well as of voltage level and frequency.

Abstract: The method for on-board electrical power distribution according to the invention includes the producing a protected segregation interface (4A) between the primary distribution (2A) and the secondary distribution network for electrical power of the cabin system (30). referred to as the cabin network, so as to comply with the quality parameters for the primary distribution (2A); controlling the extraction of electrical power from the primary distribution (2A) by a cabin management system (G1, G2) depending on the availability of electrical power on this primary distribution (2A); converting and distributing this available electrical power in the cabin network (30) according to a suitable configuration of the loads (51, 52, 53) of this cabin network (30) and defined according to an electrical configuration of type, single/three-phase AC and DC, as well as of voltage level and frequency.

Abstract: Substituted imidazolyl-alkyl-piperazine and diazepine derivatives of Formula A: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, m, n and q are defined as in the specification, and the pharmaceutically acceptable salts thereof. The compounds have calcium entry blocking activity with selectivity for cerebral blood vessels, and have protective activity against some of the deleterious effects resultant upon cerebral ischemia.

Abstract: Substituted imidazolyl-alkyl-piperazine and diazepine derivatives and the pharmaceutically acceptable salts thereof are useful for treating mammals having any of a variety of disease states. These disease states include: 1) diseases treated by direct neuronal protection, including focal and global ischemia, spinal injuries, and head trauma, and neurological diseases including Alzheimer's and Huntington's chorea; 2) uraemic and hyponatraemic encephalopathy; 3) diseases treated by diuresis; 4) diseases treated by calcium channel antagonism, including cardiovascular diseases (i.e. hypertension, angina, stable and unstable angina, Prinzmetal angina, arrhythmia, thrombosis, embolism, and congestive heart failure including chronic or acute cardiac failure), diseases characterized by ischemia of lower legs due to peripheral vascular disease (e.g., intermittent claudication), diseases characterized by spasms of smooth muscle (i.e.

Abstract: Aryl- and heterocyclic-methanamines are prepared by reacting a hydroxy-aryl carbinol or a heterocyclic carbinol with a primary or a secondary amine in the presence of a cationic effect reagent.

Abstract: Substituted imidazolyl-alkyl-piperazine and diazepine derivatives of Formula A: ##STR1## wherein: R.sup.1 is aryl, lower alkyl, cycloalkyl or hydrogen;R.sup.2 is aryl, lower alkyl or hydrogen;R.sup.3 is lower alkyl, hydroxy, or hydrogen;R.sup.4 is aryl or hydrogen;R.sup.5 is aryl or hydrogen;m is two or three;n is zero, one or two,provided that when R.sup.

Abstract: New compounds of formulas I and II ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein M is selected from the group consisting of hydrogen, morpholino, benzylamino, di-n-lower alkylamino, n-lower alkylamino and ##STR2## wherein Ar is optionally substituted phenyl; Z.sub.1 and Z.sub.2 are each independently selected from the group consisting of CH.sub.2, CHOB and C.dbd.O, wherein B is selected from the group consisting of hydrogen and alkanoyl;Y is oxygen or nothing;n is an integer from 0-4 but cannot be zero when Z.sub.1 is CHOB;m is an integer from 0-4 but cannot be zero when Z.sub.2 is CHOB;R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen, halogen, hydroxy, trifluoromethyl, alkyl or alkoxy;R.sub.4 is lower alkyl; andR.sub.5 is hydrogen or lower alkyl,are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold. They are also vasodilators.

Abstract: New compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein M is selected from the group consisting of hydrogen, morpholino, benzylamino, di-n-lower alkylamine, n-lower alkylamine, and aryl piperazino;Z.sub.1 and Z.sub.2 are each independently selected from the group consisting of CH.sub.2, CHOB and C.dbd.O, wherein B is selected from the group consisting of hydrogen and alkanoyl;Y is oxygen or sulfur;n is an integer from 0-4 but cannot be zero when Z.sub.1 is CHOB;m is an integer from 0-4 but cannot be zero when Z.sub.2 is CHOB, or when m is hydrogen;R.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen, halogen, hydroxy, trifluoromethyl, alkyl or alkoxy; andR.sub.4 and R.sub.5 are each independently lower alkyl, with the proviso that both R.sub.4 and R.sub.5 cannot be methyl when M is hydrogen;are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold.

Abstract: New compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein Z.sub.1 and Z.sub.2 are each independently selected from the group consisting of CH.sub.2, CHOB and C.dbd.O, wherein B is selected from the group consisting of hydrogen and alkanoyl;Y is oxygen or sulfur;n is an integer from 0-4 but cannot be zero when Z.sub.1 is CHOB;m is an integer from 0-4 but cannot be zero when Z.sub.2 is CHOB; andR.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen, halogen, hydroxy, trifluoromethyl, alkyl or alkoxy;are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold.

Abstract: New compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein Z.sub.1 and Z.sub.2 are each independently selected from the group consisting of CH.sub.2, CHOB and C.dbd.O, wherein B is selected from the group consisting of hydrogen and alkanoyl;Y is oxygen or sulfur;n is an integer from 0-4 but cannot be zero when Z.sub.1 is CHOB;m is an integer from 0-4 but cannot be zero when Z.sub.2 is CHOB; andR.sub.1, R.sub.2 and R.sub.3 are each independently hydrogen, halogen, hydroxy, trifluoromethyl, alkyl or alkoxy;are antihistamines and are therefore useful in the treatment of respiratory diseases including asthma, hay fever, allergies and the common cold.

Abstract: The present invention relates to compounds of the general formula: ##STR1## in which: R.sub.1 is selected from hydrogen and alkoxy having 1-7 carbon atoms,R.sub.2 is hydrogen,n is selected from zero and 1,X and Y are hydrogen atoms, andZ is hydroxy, orY and Z taken together represent an oxygen atom, or, when n=1, X and Z may represent a single bond,A represents an amino radical, and their pharmaceutically acceptable acid addition salts.These compounds are useful in particular for the treatment of asthma.

Abstract: The present invention provides compounds of formula: ##STR1## wherein R.sub.1 is selected from the group consisting of hydrogen, halog alkyl having from 1 to 6 carbon atoms, alcoxy having from 1 to 6 carbon atoms and alkylthio having from 1 to 6 carbon atoms,A taken separately is hydrogen and B is a radical with the formula ##STR2## , R.sub.3 being selected from the group consisting of hydrogen, halogen and alcoxy having from 1 to 6 carbon atoms, and A and B taken together form a radical --O--CH.sub.2 --, and the esters, N oxides and pharmacologically acceptable salts of the acids of Formula I.These compounds have analgesic and antiinflammatory properties.